Business · Companies · 14 hrs ago
Ardian plans to target Chinese companies as valuations ease
French private equity firm Ardian sees opportunities to buy quality assets in China as liquidity slows in the country.
The firm says Chinese company valuations are generally lower than in Western markets, making them attractive to investors seeking diversification.
Ardian manages more than US$200 billion in assets, according to figures from March.
Its executive president, Jan Philipp Schmitz, said the firm plans to target Chinese market leaders.
Possible sectors include technology, healthcare and business services.
European investors are showing strong demand for diversification, and Ardian says China could help meet it.
The firm has not named specific companies or said when it will make investments.
Ardian plans to target Chinese market leaders as it looks for investment opportunities amid a slowdown in liquidity.
The French private equity firm is considering companies in industries including technology, healthcare and business services.
Executive president Jan Philipp Schmitz said Chinese corporate valuations tended to be much lower than in the West.
Ardian is seeking to meet strong demand from European investors for diversification.
The firm managed more than US$200 billion in assets as of March.
- Who
- Ardian, a French private equity firm, plans to target Chinese companies.
- What
- It is looking at market leaders in industries including technology, healthcare and business services.
- When
- The plan was described in a recent interview. The firm’s assets were reported as of March.
- Where
- China.
- Why
- Ardian sees opportunities in lower corporate valuations and is seeking to meet European investors’ demand for diversification.
This story does not have two clearly opposing sides.
Ardian managed more than US$200 billion in assets.
Executive president Jan Philipp Schmitz said Ardian planned to target Chinese market leaders.
- Firm
- Ardian
- Executive
- Jan Philipp Schmitz, executive president
- Assets
- More than US$200 billion as of March
- Potential sectors
- Technology, healthcare and business services
- Investment rationale
- Chinese corporate valuations tended to be much lower than in the West